Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Receivables (2020 - 2025)

Bio Essence has reported Receivables over the past 6 years, most recently at $23454.0 for Q4 2025.

  • For Q4 2025, Receivables rose 357.73% year-over-year to $23454.0; the TTM value through Dec 2025 reached $23454.0, up 357.73%, while the annual FY2025 figure was $23454.0, 357.73% up from the prior year.
  • Receivables for Q4 2025 was $23454.0 at Bio Essence, up from $4969.0 in the prior quarter.
  • Over five years, Receivables peaked at $853248.0 in Q4 2023 and troughed at $4969.0 in Q2 2025.
  • A 5-year average of $129460.6 and a median of $23861.0 in 2021 define the central range for Receivables.
  • Biggest five-year swings in Receivables: surged 3732.51% in 2022 and later plummeted 99.4% in 2024.
  • Year by year, Receivables stood at $16820.0 in 2021, then surged by 3732.51% to $644628.0 in 2022, then skyrocketed by 32.36% to $853248.0 in 2023, then plummeted by 99.4% to $5124.0 in 2024, then soared by 357.73% to $23454.0 in 2025.
  • Business Quant data shows Receivables for BIOE at $23454.0 in Q4 2025, $4969.0 in Q3 2025, and $4969.0 in Q2 2025.